Johnson & Johnson's MONARCH Robotic Platform Achieves Over 98% Navigation Success and 83.2% Diagnostic Yield in Landmark TARGET Study

Johnson & Johnson announced that the results of its TARGET study have been published in the journalCHEST》published.This landmark study shows that clinicians useMONARCHThe accuracy rate for locating small peripheral pulmonary nodules exceeds 98%, and the safety of biopsy procedures is comparable to non-robotic bronchoscopy techniques.

TARGET Study isA single-arm prospective multicenter study that enrolled 679 patients from 21 centers in the United States, Canada, and Hong Kong, China. The patients were followed up for at least one year.

Specific Research Results

• Navigation Success Rate: The success rate of the MONARCH bronchoscope, guided by a robot, reaching the lesion is as high as 98.7%.

• Diagnostic Positive Rate: 83.2%

• Safety:Safety Characteristics and Non-Robotic BronchoscopyEquivalent。

PIEvaluation

"Providing evidence-based support for emerging technologies, especially as aNon-university-affiliated tertiary community hospital, which is crucial for advancing medical progress. I am proud to participate in the TARGET study. The results of this important research help increase clinicians' awareness of robotic-assisted bronchoscopy as a safe and effective option, therebyImprove the diagnostic and treatment standards for patients。”

---Faisal Khan  Franciscan Hospital

Executive Evaluation

"Johnson & Johnson is committed toEvidence-based ResearchTo demonstrate the safety and efficacy of our products and drive innovation in areas with significant unmet needs, asA Pioneer in the Field of Robotic Bronchoscopy, we are committed to continuously exploring its potential, in order toTransforming the Way Clinicians Diagnose and Treat Lung Cancer。”

---Ray Fryrear Johnson & JohnsonVice President of Robotics and Digital Scientific Affairs

• Endoscope----A Leap Forward in Endoscopic Technology

• Operating Handle ---- SetInnovation and Perfect User Experience Combined

Drawing on the design concept of game controllers, it allows doctors to operate with the same flexibility as playing a game, helping them safely guide the robotic endoscope to the edge of the lung.

• Host

Design considerations for mobility and system upgrades (both software and hardware can be upgraded) during clinical application. One main unit can be compatible with multiple endoscopes.

Johnson & Johnson has always been committed to addressing the most complex health challenges globally. For a century, we have driven the advancement of surgical care through innovative products such as wound closure, hemostatic assistance, surgical stapling devices, robotics, and digital solutions. Collaborating with clinical experts worldwide, we continuously revolutionize surgical techniques to better meet patient needs in metabolic diseases, cardiovascular conditions, oncology, and plastic reconstruction.